Cerenome Market Cap

Cerenome has a market cap or net worth of $12.65 million as of October 19, 2026. It is the 40,094th most valuable company in the world and the 5,481st biggest in the United States. Its market cap has decreased by 79.44% in one year.

Market Cap

12.65M

Enterprise Value

4.10M

1-Year Change

-79.44%

Global Rank

#40,094

Country Rank

#5,481 United States

ChartMarket Cap Chart

Chart

Since March 30, 2001, Cerenome's market cap has decreased from $80.80M to $12.65M, a decrease of -84.35%. That is a compound annual growth rate of -7.00%.

Market Cap History

Date	Market Cap	% Change
Oct 19, 2026	12.65M	-81.96%
Dec 31, 2025	70.10M	930.88%
Dec 31, 2024	6.80M	-13.92%
Dec 29, 2023	7.90M	-26.17%
Dec 30, 2022	10.70M	-33.54%
Dec 31, 2021	16.10M	65.98%
Dec 31, 2020	9.70M	7.78%
Dec 31, 2019	9.00M	136.84%
Dec 31, 2018	3.80M	-64.15%
Dec 29, 2017	10.60M	-65.58%
Dec 30, 2016	30.80M	5.84%
Dec 31, 2015	29.10M	-35.76%
Dec 31, 2014	45.30M	-73.86%
Dec 31, 2013	173.30M	4.90%
Dec 31, 2012	165.20M	33.66%
Dec 30, 2011	123.60M	-52.91%
Dec 31, 2010	262.50M	9.42%
Dec 31, 2009	239.90M	136.59%
Dec 31, 2008	101.40M	-33.73%
Dec 31, 2007	153.00M	18.97%
Dec 29, 2006	128.60M	10.29%
Dec 30, 2005	116.60M	202.07%
Dec 31, 2004	38.60M	-9.81%
Dec 31, 2003	42.80M	-23.84%
Dec 31, 2002	56.20M	24.89%

View and export this data all the way back to 2001. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Daré Bioscience	14.25M
Allarity Therapeutics	14.24M
Pasithea Therapeutics	14.03M
BioCardia	13.93M
Tvardi Therapeutics	13.47M
Vyome Holdings	13.12M
Lipocine	12.86M
GT Biopharma	12.68M

Market Cap Rankings